Paclitaxel (Taxol®) - A guide to administration

European Journal of Cancer Care

Volumn 5, Issue 3, 1996, Pages 147-152

  Preston, N J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Administration; Ovarian cancer; Paclitaxel (taxol ); Side effects

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

BREAST TUMOR; FEMALE; HUMAN; ONCOLOGY NURSING; OVARY TUMOR; PRACTICE GUIDELINE; REVIEW;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; ONCOLOGIC NURSING; OVARIAN NEOPLASMS; PACLITAXEL; PRACTICE GUIDELINES;

EID: 0030224169     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2354.1996.tb00226.x     Document Type: Article

References (14)

1. Bissett D. & Kaye S.B. (1993) Taxol and Taxotere - current status and clinical future prospects. European Journal of Cancer, 29A, 1228-1231.
2. Boyle N., Bertin-Matson K. & Bratschi A. (1994) A Patient's Guide to Taxol. Oncology Nursing Forum, 21, 1569-1572.
3. Cella D. F. (1995) Methods and problems in measuring quality of life. Supportive Care Cancer, 3, 11-22.
4. Chabner B.A. (1992) Taxol. PPO Updates, 5, 1-10.
5. CRC Statistics (1992) Cancer in the European Community. Fact Sheet No. 2, Cancer Research Campaign, London.
6. Crumbie A. (1994) New treatment for ovarian cancer poses ecology dilemma. Nursing Times, 90, 34-35.
7. De LaPena L.B., Pyron S. & Nichols J. (1993) Taxol: a case study. Cancer Nursing, 16, 423-430.
8. Eisenhauer E.A., ten Bokkel-Huinink W.W., Swenerton K.D., Gianni L., Myles J., van-der Burg M.E., Kerr I., Vermorken J.B., Buser K. & Colombo N. (1994) European-Canadian randomized trial of Paclitaxel (Taxol) in relapsed ovarian cancer: high dose versus low dose and long versus short infusion. Journal of Clinical Oncology, 12, 2654-2666.
9. Fallowfield L. (1990) The Quality of Life. The Missing Measurement in Health Care. Souvenir Press.
10. Feld R. (1995) Endpoints in clinical trials: is there a need for measuring quality of life? Support Care Cancer, 3, 23-27.
11. Lubejko E. & Sartorious S.E (1993) Nursing Considerations in Paclitaxel Administration. Seminars in Oncology, Suppl. 3, 20, 26-30.
12. McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E, Look K.Y. & Davidson M. (1995) Taxol and Cisplatin (TP) improves outcome in advanced ovarian cancer (AOC) as compared to Cytoxan and Cisplatin (CP) (Meeting Abstract). ASCO, 14, 771.
13. Rogers B.B. (1993) Taxol: a promising new drug of the nineties. Oncology Nursing Forum, 20, 1483-1489.
14. Rowinsky E.K., Lorraine L.A. & Donehow R.C. (1990) Taxol: a novel investigational microtubule agent. Journal of the National Cancer Institute, 82, 1247-1259.